Endpoints News48 分钟
Cure­vo gets $110M for a shot against Shin­grix, gets Mon­cef Slaoui and Tal Zaks on board
Curevo Vaccine raises $110M Series B for shingles vaccine trial extension, adds Moncef Slaoui as board chair and Moderna's ...